Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 19.90
-0.10 (-0.50%)
At close: Aug 14, 2026
Biogened Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 109.49 | 113.11 | 110.93 | 95.56 | 79.62 | 65.32 |
Revenue Growth | -4.12% | 1.97% | 16.09% | 20.02% | 21.89% | 35.15% |
Gross Profit Gross Profit Growth | 71.23 | 72.11 | 76.65 | 63.49 | 57.44 | 42.32 |
Operating Income Operating Income Growth | 9.34 | 8.26 | 9.06 | 8.16 | 8.38 | 4.59 |
Net Income Net Income Growth | 4.87 | 4.94 | 5.82 | 5.1 | 3.38 | 1.96 |
Earnings Per Share EPS Growth | 1.98 | 2.01 | 2.37 | 2.08 | 1.38 | 0.80 |
EPS Growth | -19.32% | -15.11% | 14.22% | 50.74% | 72.46% | 57.92% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Poland Poland Growth | 5,569 |
Export Export Growth | 5,742 |
Total Total Growth | 11,311 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.13 | 6.32 | 6.07 | 7.51 | 3.46 | 4.97 |
Total Debt Total Debt Growth | 29.18 | 24.25 | 26.1 | 22.46 | 22.98 | 18.7 |
Net Cash (Debt) Net Cash Growth | -22.04 | -17.92 | -20.03 | -14.94 | -19.52 | -13.74 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.97 | -7.30 | -8.16 | -6.08 | -7.95 | -5.59 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 11.45 | 12.47 | 4 | 14.87 | 6.01 | 3.14 |
Capital Expenditures CapEx Growth | -7.96 | -7.35 | -5.49 | -7.15 | -9.36 | -1.57 |
Free Cash Flow Free Cash Flow Growth | 3.49 | 5.13 | -1.49 | 7.72 | -3.35 | 1.57 |
Free Cash Flow Growth | -13.97% | - | - | - | - | -77.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.05% | 63.75% | 69.10% | 66.44% | 72.14% | 64.78% |
Operating Margin | 8.53% | 7.30% | 8.16% | 8.54% | 10.52% | 7.03% |
Pretax Margin | 6.63% | 5.29% | 6.94% | 7.21% | 8.03% | 6.63% |
Profit Margin | 4.45% | 4.37% | 5.25% | 5.33% | 4.25% | 3.00% |
FCF Margin | 3.19% | 4.53% | -1.35% | 8.08% | -4.21% | 2.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | - | 0.500 | 0.500 | 0.400 |
Dividend Per Share Growth | 0% | - | 0% | 25.00% | - |
Dividend Yield | 2.51% | - | 2.22% | 2.89% | 3.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.04 | 10.74 | 9.70 | 8.67 | 9.23 | 10.77 |
P/FCF Ratio | 13.99 | 10.35 | - | 5.73 | - | 13.43 |
PS Ratio | 0.45 | 0.47 | 0.51 | 0.46 | 0.39 | 0.32 |